Molecular Partners Stock Forward View - Simple Moving Average
| MOLN Stock | CHF 3.32 -0.03 -0.90% |
This page provides Simple Moving Average reference data for Molecular Partners AG, calculated from historical daily prices. The model output shown here is derived from Molecular Partners's historical price series and is provided for informational purposes. Projected values and accuracy measures are included for reference.
The Simple Moving Average forecasted value of Molecular Partners AG on the next trading day is expected to be 3.32 with a mean absolute deviation of 0.1 and the sum of the absolute errors of 5.75.The simple moving average model is conceptually a linear regression of the current value of Molecular Partners AG price series against current and previous (unobserved) value of Molecular Partners. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future The Simple Moving Average reference information for Molecular Partners is based on available price data and is intended for informational purposes. Simple Moving Average Price Forecast For the 28th of March
Given 90 days horizon, the Simple Moving Average forecasted value of Molecular Partners AG on the next trading day is expected to be 3.32 with a mean absolute deviation of 0.1 , mean absolute percentage error of 0.02 , and the sum of the absolute errors of 5.75 .Please note that although there have been many attempts to predict Molecular Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Molecular Partners' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Molecular Partners | Molecular Partners Price Prediction | Research Analysis |
Forecasted Value
Forecasting Molecular Partners AG for the next session involves measuring the model's historical ability to define credible downside and upside scenarios. The projected forecast band currently runs from roughly 0.03 on the downside to about 7.42 on the upside.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Molecular Partners stock data series using in forecasting. Note that when a statistical model is used to represent Molecular Partners stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.2878 |
| Bias | Arithmetic mean of the errors | 0.0024 |
| MAD | Mean absolute deviation | 0.0958 |
| MAPE | Mean absolute percentage error | 0.0274 |
| SAE | Sum of the absolute errors | 5.745 |
Other Forecasting Options for Molecular Partners
The autocorrelation structure of Molecular Partners' daily returns reveals whether Molecular exhibits momentum, mean-reversion, or random-walk behavior. Separating these elements helps distinguish persistent directional moves from temporary noise in Molecular Stock price data. Stochastic oscillator analysis compares Molecular Partners' closing price to its range over a given period.Molecular Partners Related Equities
Checking Molecular Partners against related firms within the Health Care space helps investors see where the stock stands among peers. Key comparison metrics include price-to-earnings, profit margin, and revenue growth across Molecular Partners' peer group.
| Risk & Return | Correlation |
Molecular Partners Market Strength Events
Market strength indicators applied to Molecular Partners stock help assess momentum and resilience across environments. These indicators support informed market timing decisions when analyzing Molecular Partners. For Molecular Partners AG, market strength indicators complement fundamental analysis with timing context.
Molecular Partners Risk Indicators
Risk indicator analysis for Molecular Partners is essential for accurately projecting its future price trajectory. The process involves identifying the amount of risk involved in Molecular Partners' investment and either accepting or mitigating it. Understanding the risk profile of Molecular Partners' allows investors to make more informed decisions about position sizing.
| Mean Deviation | 2.75 | |||
| Semi Deviation | 3.39 | |||
| Standard Deviation | 4.05 | |||
| Variance | 16.39 | |||
| Downside Variance | 13.0 | |||
| Semi Variance | 11.52 | |||
| Expected Short fall | -3.17 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Molecular Partners
A coverage review of Molecular Partners AG shows when the security is attracting above-average attention from contributors and market observers. This is most useful when investors want to understand why a security is suddenly drawing more public discussion.
Other Macroaxis Stories
Macroaxis story coverage is designed for a broad investing audience that ranges from self-directed traders to advisers, researchers, and institutional market participants. The content is intended to support people who want a more structured path from headline information to portfolio action.
Story Categories
Currently Trending Categories
Molecular Partners Short Properties
Short-interest signals around Molecular Partners AG can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. This is most valuable when investors want to know whether bearish pressure is starting to shape the market's reaction function.
| Common Stock Shares Outstanding | 37.3 M | |
| Cash And Short Term Investments | 93.1 M |
Additional Tools for Molecular Stock Analysis
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to identify potential trend changes across multiple global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |